Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2021 Apr;73(4):498–509. doi: 10.1002/acr.24140

Table 4.

Hazard ratios for incident asthma after blood draw date, comparing women with RA to their matched controls in the Nurses’ Health Studies (n=951).

Incident asthma
cases/person-years
HR (95%CI) controlling
for matching factors*
Multivariable**
HR (95%CI)
Pre-RA ACPA+ (n=49) 8/890 1.71 (0.72, 4.07) 1.74 (0.72, 4.24)
Matched controls (n=136) 14/2,660 1.00 (Ref) 1.00 (Ref)
Pre-RA ACPA− (n=203) 31/3,777 1.73 (1.11, 2.70) 1.62 (1.04, 2.55)
Matched controls (n=563) 52/11,039 1.00 (Ref) 1.00 (Ref)
All pre-RA (n=252) 39/4,667 1.72 (1.16, 2.56) 1.65 (1.11, 2.46)
Matched controls (n=699) 66/13,698 1.00 (Ref) 1.00 (Ref)

P for pre-RA/control status-ACPA status interaction in unadjusted analysis: 0.20

P for pre-RA/control status-ACPA status interaction in adjusted analysis: 0.23

*

Each woman with RA was matched to 3 controls by age, time from blood draw to index date, cohort, calendar year, fasting status/time of day at blood draw, menopausal status, and postmenopausal hormone use.

**

Additionally adjusted for smoking (continuous pack-years), body mass index (continuous, kg/m2), and median household income (quartile).

ACPA, anti-citrullinated protein antibodies; CI, confidence interval; HR, hazard ratio; RA, rheumatoid arthritis.